Drug Delivery from the Oral Cavity: A Focus on Mucoadhesive Buccal Drug Delivery Systems

References

1. 1.↵
   1. Robinson D. H.,
   2. Mauger J. W.

   Drug delivery systems. Am. J. Hosp. Pharm. 1991, 48, S14–S23.

   OpenUrlAbstract
2. 2.↵
   1. Ullyot S. C.

   Paediatric premedication. Can. J. Anaesth. 1992, 39, 533–536.

   OpenUrlPubMedWeb of Science
3. 3.↵
   1. Bandyopadhyay A. K.,
   2. Sudhakar Y.

   Advances in buccal adhesive drug delivery. Drug Delivery Technology 2006, 6 (6), 51–55.

   OpenUrl
4. 4.↵
   1. Giannola L. I.,
   2. De Caro V.,
   3. Giandalia G.,
   4. Siragusa M. G.,
   5. Campisi G.

   Current status in buccal drug delivery. Wolff Pharmaceutical Technology Europe. May 1, 2008.
5. 5.↵
   1. Khanna R.,
   2. Agarwal S. P.,
   3. Alka A.

   Mucoadhesive buccal drug delivery: a potential alternative to conventional therapy. Indian J. Pharm. Sci. 1998, 60 (l), 1–11.

   OpenUrl
6. 6.↵
   1. Miller N. S.,
   2. Chittchang M.,
   3. Johnston T. P.

   The use of mucoadhesive polymers in buccal drug delivery. Adv. Drug Deliv. Rev. 2005, 57 (1), 1666–1691.

   OpenUrlPubMed
7. 7.↵
   1. Vyas S. P.,
   2. Khar R. K.

   Controlled Drug Delivery—Concepts and Advances, 1st ed.; Vallabh Prakashan: New Delhi, 2002.
8. 8.↵
   1. Veillard M. M.,
   2. Longer M.,
   3. Martens T. W.,
   4. Robinson J. R.

   Preliminary studies of oral mucosal delivery of peptide drugs. J. Controlled Release 1987, 6 (1), 123–131.

   OpenUrl
9. 9.↵
   1. Alka G.,
   2. Sanjay G.,
   3. Khar R. K.

   Mucoadhesive buccal drug delivery systems: a review. Indian Drugs 1992, 13 (29), 586–593.

   OpenUrl
10. 10.↵
    1. Khanna R.,
    2. Agarwal S. P.,
    3. Alka A.

    Mucoadhesive buccal drug delivery: a potential alternative to conventional therapy. Indian J. Pharm Sci. 1998, 60 (l), 1–11.

    OpenUrl
11. 11.↵
    1. Lehr C. M.

    Lectin-mediated drug delivery: the second generation of bioadhesives. J. Controlled Release 2000, 65 (1–2), 19–29.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Meyer J.,
    2. Squier C. A.,
    3. Gerson S. J.

    1. Chen Y. S.,
    2. Squier C. A.

    The Ultrastructure of the Oral Epithelium. In The Structure and Function of Oral Mucosa; Meyer J., Squier C. A., Gerson S. J. Eds.; Pergamon Press: Oxford, 1984; pp 7–30.
13. 13.↵
    1. Harris D.,
    2. Robinson J. R.

    Drug delivery via the mucous membranes of the oral cavity. J. Pharm Sci. 1992, 81 (1), 1–10.

    OpenUrlPubMedWeb of Science
14. 14.↵
    1. Hillery A. M.,
    2. Lloyd A. W.

    Oral Transmucosal Drug Delivery, Controlled and Targeted Drug Delivery System; Taylor & Francis: London and New York, 2001; p 182.
15. 15.↵
    1. de Boer A. G.,
    2. van Hoogdalem E. J.,
    3. Breimer D. D.

    Improvement of drug absorption through enhancers. Eur. J. Drug Metab. Pharmacokinet. 1990, 15 (2), 155–157.

    OpenUrlPubMedWeb of Science
16. 16.↵
    1. Singh J.,
    2. Roberts M. S.

    Transdermaldelivery of drugs by iontophoresis: a review. Drug Des. Deliv. 1989, 4 (1), 1–12.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Motwani J. G.,
    2. Lipworth B. J.

    Clinicalpharmacokinetics of drugs administered buccally and sublingually. Clin. Pharmacokinet. 1991, 21 (2), 83–94.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. van Hoogdalem E.,
    2. de Boer A. G.,
    3. Breimer D. D.

    Pharmacokineticsof rectal drug administration. Part I: general considerationsand clinical applications of centrally acting drugs. Clin. Pharmacokinet, 1991, 21 (1), 11–26.

    OpenUrlPubMedWeb of Science
19. 19.↵
    1. Weinberg D. S.,
    2. Inturrisi C. E.,
    3. Reidenberg B.,
    4. Moulin D. E.,
    5. Nip T. J.,
    6. Wallenstein S.,
    7. Houde R. W.,
    8. Foley K. M.

    Sublingualabsorption of selected opioid analgesics. Clin. Pharmacol. Ther. 1988, 44 (3), 335–342.

    OpenUrlPubMedWeb of Science
20. 20.↵
    Editorial. Administration of drugs by the buccal route. Lancet 1987, 1, 666–667.

    OpenUrlPubMedWeb of Science
21. 21.↵
    1. de Vries M. E.,
    2. Boddé H. E.,
    3. Verhoef J. C.,
    4. Junginger H. E.

    Developments in buccal drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 1991, 8 (3), 271–303.

    OpenUrlPubMedWeb of Science
22. 22.↵
    1. Jantzen J. P.,
    2. Erdmann K.,
    3. Witton P. K.,
    4. Klein A. M.

    Theeffect of rectal pH values on the absorption of methohexital. Anaesthetist 1986, 35 (8), 496–499.

    OpenUrlPubMedWeb of Science
23. 23.↵
    1. Kimura T.,
    2. Yamano H.,
    3. Tanaka A.,
    4. Matsumara T.,
    5. Ueda M.,
    6. Ogawara K.

    Transport of D-glucose across cultured stratified cell layer of human oral mucosal cells. J. Pharm. Pharmacol. 2002, 54 (2), 213–219.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. Sudhakar Y.,
    2. Kuotsu K.,
    3. Bandyopadhyay A. K.

    Buccal bioadhesive drug delivery—a promising option for orally less efficient drugs. J. Controlled Release 2006, 114 (1), 15–40.

    OpenUrlCrossRefPubMedWeb of Science
25. 25.↵
    1. Randhawa M. A.,
    2. Malik S. A.,
    3. Javed M.

    Buccal absorption of weak acidic drugs is not related to their degree of ionization as estimated from the Henderson-Hasselbalch equation. Pakistan J. Med. Res. 2003, 42 (2), 45–49.

    OpenUrl
26. 26.↵
    1. Attia M. A.,
    2. El-Gibaly I.,
    3. Shaltout S. E.,
    4. Fetih G. N.

    Transbuccal permeation, anti-inflammatory activity and clinical efficacy of piroxicam formulated in different gels. Int. J. Pharm. 2004, 276 (1–2), 11–28.

    OpenUrlPubMed
27. 27.↵
    1. van der Mei H. C.,
    2. White D. J.,
    3. Busscher H. J.

    Biomechanical analysis of shoulder arthroplasty. Arch. Oral Biol. 2004, 49, 671–673.

    OpenUrlCrossRefPubMed
28. 28.↵
    1. Birudaraj R.,
    2. Mahalingam R.,
    3. Li X.,
    4. Jasti B. R.

    Advances in buccal drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 2005, 22 (3), 295–300.

    OpenUrlPubMed
29. 29.↵
    1. van Eyk A. D.,
    2. van der Bijl P.

    Comparative permeability of various chemical markers through human vaginal and buccal mucosa as well as porcine buccal and mouth floor mucosa. Arch. Oral Biol. 2004, 49 (5), 387–392.

    OpenUrlCrossRefPubMed
30. 30.↵
    1. Nielsen H. M.,
    2. Rassing M. R.

    TR146 cells grown on filters as a model of human buccal epithelium: IV. Permeability of water, mannitol, testosterone and beta-adrenoceptor antagonists. Comparison to human, monkey and porcine buccal mucosa. Int. J. Pharm. 2000, 194 (2), 155–167.

    OpenUrlCrossRefPubMedWeb of Science
31. 31.↵
    1. Pramod Kumar T. M.,
    2. Desai K. G.,
    3. Shivkumar H. G.

    Mechanism of buccal permeation enhancers. Indian J. Pharm. Educ. 2002, 36 (3), 147–151.

    OpenUrl
32. 32.↵
    1. McElnay A. C.,
    2. Swarbrick J.,
    3. Boyloan J. C.

    Encyclopedia of Pharmaceutical Technology; Marcel Dekker: New York; 1988, Vol. 2; p 189.

    OpenUrl
33. 33.↵
    1. Nicolazzo J. A.,
    2. Reed B. L.,
    3. Finnin B. C.

    Buccal penetration enhancers—how do they really work? J. Controlled Release 2005, 105 (1–2), 1–15.

    OpenUrl
34. 34.↵
    1. Williams A. C.,
    2. Barry B. W.

    Penetration enhancer. Adv. Drug Deliv. Rev. 2004, 56 (5), 603–618.

    OpenUrlCrossRefPubMedWeb of Science
35. 35.↵
    1. Starokadomskyy P. L.,
    2. Dubey I. Y.

    New absorption promoter for the buccal delivery: preparation and characterization of lysalbinic acid. Int. J. Pharm. 2006, 308 (1–2), 149–154.

    OpenUrlPubMed
36. 36.↵
    1. Lavon I.,
    2. Grossman N.,
    3. Joseph K.,
    4. Kimmel E.,
    5. Enden G.

    Bubble growth within the skin by rectified diffusion might play a significant role in sonophoresis. J. Controlled Release 2007, 117 (2), 246–255.

    OpenUrlPubMed
37. 37.↵
    1. Mitragotri S.,
    2. Kost J.

    Low-frequency sonophoresis: a review. Adv. Drug Deliv. Rev. 2004, 56 (5), 589–601.

    OpenUrlCrossRefPubMedWeb of Science
38. 38.↵
    1. Kalia Y. N.,
    2. Naik A.,
    3. Garrison J.,
    4. Guy R. H.

    Iontophoretic drug delivery. Adv. Drug Deliv. Rev. 2004, 56 (5), 619–658.

    OpenUrlCrossRefPubMedWeb of Science
39. 39.↵
    1. Denet A. R.,
    2. Vanbever R.,
    3. Preat V.

    Skin electroporation for transdermal and topical delivery. Adv. Drug Deliv. Rev. 2004, 56 (5), 659–674.

    OpenUrlCrossRefPubMedWeb of Science
40. 40.↵
    1. Longer M. A.,
    2. Robinson J. R.

    Fundamental aspects of bioadhesion. Pharm. Int. 1986, 7, 114–117.

    OpenUrl
41. 41.↵
    1. Gandhi R. B.,
    2. Robinson J. R.

    Oral cavity as a site for bioadhesive drug delivery. Adv. Drug Deliv. Rev. 1994, 13 (1–2), 43–74.

    OpenUrl
42. 42.↵
    1. Duchěne D.,
    2. Touchard F.,
    3. Peppas N. A.

    Pharmaceutical and medical aspects of bioadhesive systems for drug administration. Drug Dev. Ind. Pharm. 1988, 14 (2–3), 283–318.

    OpenUrl
43. 43.↵
    1. Peppas N. A.

    Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues. J. Controlled Release 1985, 2, 257.

    OpenUrlCrossRef
44. 44.↵
    1. Ugwoke M. I.,
    2. Agu R. U.,
    3. Verbeke N.,
    4. Kinget R.

    Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives. Adv. Drug Deliv. Rev. 2005, 57 (11), 1640–1665.

    OpenUrlCrossRefPubMed
45. 45.↵
    1. van Wachem P. B.,
    2. Beugeling T.,
    3. Feijen J.,
    4. Bantjes A.,
    5. Detmers J. P.,
    6. van Aken W. G.

    Interaction of cultured human endothelial cells with polymeric surfaces of different wettabilities. Biomaterials 1985, 6 (6), 403–408.

    OpenUrlCrossRefPubMedWeb of Science
46. 46.↵
    1. Dodou P.,
    2. Breedveld P.,
    3. Wieringa P. A.

    Mucoadhesives in the gastrointestinal tract: revisiting the literature for novel applications. Eur. J. Pharm. Biopharm. 2005, 60 (1), 1–16.

    OpenUrlCrossRefPubMedWeb of Science
47. 47.↵
    1. Derjaguin B. V.,
    2. Smilga V. P.

    The electronic theory of adhesion. In: Adhesion: Fundamentals and Practice; University of Notingham, England andGordon & Breach: New York, 1996.
48. 48.↵
    1. Andrews G. P.,
    2. Laverty T. P.,
    3. Jones D. S.

    Mucoadhesive polymeric platforms for controlled drug delivery. Eur. J. Pharm. Biopharm. 2009, 71 (3), 505–518.

    OpenUrlCrossRefPubMed
49. 49.↵
    1. Lee J. W.,
    2. Park J. H.,
    3. Robinson J. R.

    Bioadhesive-based dosage forms: the next generation. J. Pharm. Sci. 2000, 89 (7), 850–866.

    OpenUrlCrossRefPubMed
50. 50.↵
    1. Gupta A.,
    2. Garg S.,
    3. Khar R. K:

    Mucoadhesive buccal drug delivery systems: areview. Indian Drugs 1992, 29 (13), 586–593.

    OpenUrl
51. 51.↵
    1. Jain N. K.

    1. Khar K.,
    2. Ahuja A.,
    3. Javed A.

    Mucoadhesive Drug Delivery. In Controlled and Novel Drug Delivery, 1st ed.; Jain N. K. Ed.; CBS Publishers and Distributors, New Delhi, 1997.
52. 52.↵
    1. Jimenez-Castellanos M. R.,
    2. Zia H.,
    3. Rhodes C. T.

    Mucoadhesive drug delivery systems. Drug Dev. Ind. Pharm. 1993, 19 (1–2), 143–194.

    OpenUrl
53. 53.↵
    1. Ahuja A.,
    2. Khar R. K.,
    3. Ali J.

    Mucoadhesive drug delivery systems. Drug Dev. Ind. Pharm. 1997, 23 (5), 489–515.

    OpenUrl
54. 54.↵
    1. Wise D. L.

    1. Peppas N. A.,
    2. Little M. D.,
    3. Huang Y.

    Bioadhesive ControlledRelease Systems. In Handbook of Pharmaceutical Controlled Release Technology; Wise D. L. Ed.; Marcel Dekker: New York, 2000; pp 255–269.
55. 55.↵
    1. Tiwari D.,
    2. Goldman D.,
    3. Sause R.,
    4. Madan P. L.

    Evaluation of polyoxyethylene homopolymers for buccal bioadhesive drug delivery device formulations. AAPS PharmSci 1999, 1 (3), 50–57.

    OpenUrl
56. 56.↵
    1. Huang Y.,
    2. Leobandung W.,
    3. Foss A.,
    4. Peppas N. A.

    Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces. J. Controlled Release 2000, 65 (1–2), 63–71.

    OpenUrlCrossRefPubMedWeb of Science
57. 57.↵
    1. Park K.,
    2. Robinson J. R.

    Mechanisms of mucoadhesion of poly(acrylic acid) hydrogels. Pharm Res. 1987, 4 (6), 457–464.

    OpenUrlPubMed
58. 58.↵
    1. Hagerstrom H.,
    2. Paulsson M.,
    3. Edsman K.

    Evaluation of mucoadhesion for two polyelectrolyte gels in simulated physiological conditions using a rheological method. Eur. J. Pharm. Sci. 2000, 9 (3), 301–309.

    OpenUrlPubMed
59. 59.↵
    1. Sigurdsson H.,
    2. Loftsson T.,
    3. Lehr C.

    Assessment of mucoadhesion by a resonant mirror biosensor. Int. J. Pharm. 2006, 325 (1–2), 75–81.

    OpenUrlPubMed
60. 60.↵
    1. Mortazavi S. A.,
    2. Smart J.

    An investigation into the role of water movement and mucus gel dehydration in mucoadhesion. J. Controlled Release 1993, 25 (3), 197–203.

    OpenUrl
61. 61.↵
    1. Flory P. J.

    Principlse of Polymer Chemistry; Cornell University Press: Ithaca, New York, 1953; pp 541–556.
62. 62.↵
    1. Park K.,
    2. Robinson J. R.

    Bioadhesive polymers as platforms for oral controlled drug delivery: method to study bioadhesion. Int J. Pharm. 1984, 19 (2), 107–127.

    OpenUrlCrossRefWeb of Science
63. 63.↵
    1. Anderson J. M.,
    2. Kim S. W.

    1. Park K.,
    2. Ch'ng H. S.,
    3. Robinson J. R.

    Alternative approaches to oral-controlled drug delivery: bioadhesive and in situ systems. In Recent Advances in Drug Delivery Systems; Anderson J. M., Kim S. W. Eds.; Plenum Press: New York, 1984; p 163.
64. 64.↵
    1. Ch'ng H. S.,
    2. Park K.,
    3. Kelly P.,
    4. Robinson J. R.

    Bioadhesive polymers as platform for oral controlled drug delivery. II. Synthesis and evaluation of some swelling, water-insoluble bioadhesive polymers. J. Pharm Sci. 1985, 74 (4), 399–404.

    OpenUrlPubMed
65. 65.↵
    1. Park H.,
    2. Amiji M.,
    3. Park K.

    Mucoadhesive hydrogels effective at neutral pH. Proc. Int. Symp. Control. Release Bioact. Mater. 1989, 16, 217–218.

    OpenUrl
66. 66.↵
    1. Asane G. S.,
    2. Nirmal S. A.,
    3. Rasal K. B.,
    4. Naik A. A.,
    5. Mahadik M. S.,
    6. Rao Y. R.

    Polymers for mucoadhesive drug delivery system: acurrent status. Drug Dev. Ind. Pharm. 2008, 34 (11), 1246–1266.

    OpenUrlPubMed
67. 67.↵
    1. Salamat-Miller N.,
    2. Chittchang M.,
    3. Johnston T. P.

    The use of mucoadhesive polymers in buccal drug delivery. Adv. Drug. Del. Rev. 2005, 57 (11), 1666–1691.

    OpenUrlPubMed
68. 68.↵
    1. Swarbrick J.,
    2. Boylan J. C.

    1. Kamath K. R.,
    2. Park K.

    Mucosal Adhesive Preparations. In Encyclopedia of Pharmaceutical Technology; Swarbrick J., Boylan J. C. Eds.; Marcel Dekker: New York, 1994; pp 133–138.
69. 69.↵
    1. Lehr C. M.,
    2. Poelma F. C. G.,
    3. Junginger H. E.,
    4. Tukker J. J.

    An estimate of turnover time of intestinal mucus gel layer in the rats, in situ loop. Int. J. Pharm. 1991, 70 (1), 235–240.

    OpenUrl
70. 70.↵
    1. Ugwoke M. I.,
    2. Agu R. U.,
    3. Verbeke N.,
    4. Kinget R.

    Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives. Adv. Drug Del. Rev. 2005, 57 (11), 1640–1665.

    OpenUrlCrossRefPubMed
71. 71.↵
    1. Shojaei A. H.

    Buccal mucosa as a route for systemic drug delivery: a review. J. Pharm. Pharm. Sci. 1998, 1 (1), 15–30.

    OpenUrlPubMed
72. 72.↵
    1. Gu J. M.,
    2. Robinson J. R.,
    3. Leung S. H.

    Binding of acrylic polymers to mucin/epithelial surfaces: structure-property relationships. Crit. Rev. Ther. Drug Carr. Syst. 1998, 5 (1), 21–67.

    OpenUrl
73. 73.↵
    1. Lee J. W.,
    2. Park J. H.,
    3. Robinson J. R.

    Bioadhesive-based dosage forms: the next generation. J. Pharm. Sci. 2000, 89 (7), 850–866.

    OpenUrlCrossRefPubMed
74. 74.↵
    1. Andrews G. P.

    Mucoadhesive polymeric platforms for controlled drug delivery. Eur. J. Pharm. Biopharm. 2009, 71, 505–518.

    OpenUrlCrossRefPubMed
75. 75.↵
    1. Onishi H.,
    2. Machida Y.

    Biodegradation and distribution of water soluble chitosan in mice. Biomaterials 1999, 20, 175–182.

    OpenUrlCrossRefPubMedWeb of Science
76. 76.↵
    1. Clark M. A.,
    2. Hirst B.,
    3. Jepson M.

    Lectin-mediated mucosal delivery of drugs and microparticles. Adv. Drug Deliv. Rev. 2000, 43 (2–3), 207–223.

    OpenUrlCrossRefPubMedWeb of Science
77. 77.↵
    1. Bruschi M. L.,
    2. de Freitas O.

    Oral bioadhesive drug delivery systems. Drug Dev. Ind. Pharm. 2005, 31 (3), 293–310.

    OpenUrlPubMed
78. 78.↵
    1. Gandhi R. B.,
    2. Robinson J. R.

    Oral cavity as a site for bioadhesive drug delivery. Adv. Drug Deliv. Rev. 1994, 13 (1–2), 43–74.

    OpenUrl
79. 79.↵
    1. Rathbone M. J.,
    2. Drummond B. K.,
    3. Tucker I. G.

    The oral cavity as a site for systemic drug delivery. Adv. Drug Deliv. Rev. 1994, 13 (1–2), 1–22.

    OpenUrl
80. 80.↵
    1. Anders R.,
    2. Merkle H. P.

    Evaluation of laminated mucoadhesive patches for buccal drug delivery. Int. J. Pharm. 1989, 49 (3), 231–240.

    OpenUrl
81. 81.↵
    1. Khanvilkar K.,
    2. Donovan M. D.,
    3. Flanagan D. R.

    Drug transfer through mucus. Adv. Drug Deliv. Rev. 2001, 48 (2–3), 173–193.

    OpenUrlCrossRefPubMedWeb of Science
82. 82.↵
    1. Jain A. C.,
    2. Aungst B. J.,
    3. Adeyeye M. C.

    Development and in vivo evaluation of buccal tablets prepared using danazolsulfobutylether 7 β-cyclodextrin (SBE 7) complexes. J. Pharm. Sci. 2002, 91 (7), 1659–1668.

    OpenUrlPubMed
83. 83.↵
    1. Veuillez F.,
    2. Kalia Y. N.,
    3. Jacques Y.,
    4. Deshusses J.,
    5. Buri P.

    Factors and strategies for improving buccal absorption of peptides. Eur. J. Pharm. Biopharm. 2001, 51 (2), 93–109.

    OpenUrlCrossRefPubMed
84. 84.↵
    1. de Vries M. E.,
    2. Boddé H. E.,
    3. Verhoef J. C.,
    4. Junginger H. E.

    Developments in buccal drug delivery. Crit. Rev. Ther. Drug Carr. Syst. 1991, 8 (3), 271–303.

    OpenUrlPubMedWeb of Science
85. 85.↵
    1. Mathiowitz E.,
    2. Chickering D. E. III.,
    3. Lehr C. M.

    1. Lueßen H. L.,
    2. Verhoef J. C.,
    3. de Bore A. G.,
    4. Junginger H. E.,
    5. de Leeuw B. J.,
    6. Borchard G.,
    7. Lehr C. M.

    Multifunctional Polymers for the Peroral Delivery of Peptide Drugs. In Bioadhesive Drug Delivery Systems. Fundamentals, Novel Approaches, and Development; Mathiowitz E., Chickering D. E. III., Lehr C. M. Eds.; Marcel Dekker: New York, 1999; pp 299–339.
86. 86.↵
    1. Park H.,
    2. Robinson J. R.

    Physicochemical properties of water insoluble polymers important to mucin epithelial adhesion. J. Controlled Release 1985, 2, 47–57.

    OpenUrl
87. 87.↵
    1. Gennaro A. R.

    1. Rudnic E. M.,
    2. Schwartz J. D.

    Oral Solid Dosage Forms. In Remington: The Science and Practice of Pharmacy, 20th ed.; Gennaro A. R. Ed.; Lippincott Williams & Wilkins: Baltimore, MD, 2000; pp 858–859.
88. 88.↵
    1. Irache J. M.,
    2. Huici M.,
    3. Konecny M.,
    4. Espuelas S.,
    5. Campanero M. A.,
    6. Arbos P.

    Bioadhesive properties of Gantrez nanoparticles. Molecules 2005, 10 (1), 126–145.

    OpenUrlPubMed
89. 89.↵
    1. Junginger H. E.,
    2. Hoogstraate J. A.,
    3. Verhoef J. C.

    Recent advances in buccal drug delivery and absorption—in vitro and in vivo studies. J. Controlled Release 1999, 62 (1–2), 149–159.

    OpenUrlCrossRefPubMedWeb of Science
90. 90.↵
    1. Ramesha B.,
    2. Chary R.,
    3. Vani G.,
    4. Madhusudan R. Y.

    In vitro and in vivo adhesion testing of mucoadhesive drug delivery systems. Drug Dev. Ind. Pharm. 1999, 25 (5), 685–690.

    OpenUrlPubMed
91. 91.↵
    1. Bologna W. J.,
    2. Levine H. L.,
    3. Cartier P.,
    4. de Ziegler D.

    Bioadhesive Progressive Hydration Tablets and Methods of Making and Using the Same. U.S. Patent 6,248,358, August 23, 1999.
92. 92.↵
    1. Batchelor H.

    Strategies in mucosal-adhesive drug delivery. CRS Newsletter 2005, 22 (1), 4–5.

    OpenUrl
93. 93.↵
    1. Nafee N. A.,
    2. Ismail F. A.,
    3. Boraie N. A.,
    4. Mortada L. M.

    Mucoadhesive delivery systems. I. Evaluation of mucoadhesive polymers for buccal tablet formulation. Drug Dev Ind. Pharm. 2004, 30 (9), 985–993.

    OpenUrlPubMed
94. 94.↵
    1. Batchelor H.

    Novel bioadhesive formulations in drug delivery. The Drug Delivery Companies Report 2004, Pharma. Ventures Ltd., Autumn/Winter.
95. 95.↵
    1. Dowty M. E.,
    2. Knuth K. E.,
    3. Robinson J. R.

    Enzyme characterization studies on the rate-limiting barrier in rabbit buccal mucosa. Int. J. Pharm. 1992, 88 (1–3), 293–302.

    OpenUrl
96. 96.↵
    1. Mehta M.,
    2. Kemppainen B. W.,
    3. Staffford R. G.

    In vitro penetration of tritium-labelled water (THO) and [3H]PbTx-3 (a red tide toxin) through monkey buccal mucosa and skin. Tox. Lett. 1991, 55 (2), 185–194.

    OpenUrl
97. 97.↵
    1. Quadros E.,
    2. Cassidy J.,
    3. Gniecko K.,
    4. Le Roy S.

    Buccal and colonic absorption of CGS 16617, a novel ACE inhibitor. J. Controlled Release 1991, 19 (1–3), 77–86.

    OpenUrl
98. 98.↵
    1. Squier C. A.,
    2. Hall B. K.

    The permeability of skin and oral mucosa to water and horseradish peroxidase as related to the thickness of the permeability barrier. J. Invest. Dermatol. 1985, 84 (3), 176–179.

    OpenUrlPubMedWeb of Science
99. 99.↵
    1. Hoogstraate A. J.,
    2. Cullander C.,
    3. Nagelkerke J. F.,
    4. Verhoel J.,
    5. Junginger H. E.,
    6. Bodde H. E.

    Diffusion rates and transport pathways of FITC-labelled model compounds through buccal epithelium. Proceed. Int. Symp. Control. Rel. Bioact. Mater. 1993, 20, 234–235.

    OpenUrl
100. 100.↵
     1. Collins P.,
     2. Laffoon J.,
     3. Squier C. A.

     Comparative study of porcine oral epithelium. J. Dent. Res. 1981, 60, 543.

     OpenUrl
101. 101.↵
     1. Reddy P. C.,
     2. Rao Y. M.

     A review on bioadhesive buccal drug delivery systems: current status of formulation and evaluation methods. DARU Journal of Pharmaceutical Sciences 2011, 19 (6), 385–403.

     OpenUrlPubMed
102. 102.↵
     1. Reddy P. C.,
     2. Ramesh G.,
     3. Vishnu Y. V.,
     4. Kumar Y. S.,
     5. Rao Y. M.

     Development of bilayered mucoadhesive patches for buccal delivery of felodipine: in vitro and ex vivocharacterization. Curr. Trends Biotech. Pharm. 2010, 4 (2), 673–683.

     OpenUrl
103. 103.↵
     1. Ghebre-Sellassie I.,
     2. Martin C.

     1. Luker K.

     Single-Screw Extrusion and Screw Design. In Pharmaceutical Extrusion Technology. Drugs and the Pharmaceutical Sciences; Ghebre-Sellassie I., Martin C. Eds.; Marcel Dekker: New York, 2003; Vol. 133, pp 39–68.

     OpenUrl
104. 104.↵
     1. Ndindayino F.,
     2. Henrist D.,
     3. Kiekens F.,
     4. Van den Mooter G.,
     5. Vervaet C.,
     6. Remon J. P.

     Direct compression properties of melt-extruded isomalt. Int. J. Pharm. 2002, 235 (1–2), 149–151.

     OpenUrlPubMed
105. 105.↵
     1. Lee J.,
     2. Kellaway I. W.

     Buccal permeation of (D-Ala2, DLeu5) enkephalin from liquid crystalline phases of glyceryl monooleate. Int. J. Pharm. 2000, 195, 35–38.

     OpenUrlPubMed
106. 106.↵
     1. Jug M.,
     2. Becirevic-Lacan M.

     Influence of hydroxypropyl-B-cyclodextrin complexation on piroxicam release from buccoadhesive tablets. Eur. J. Pharm. Sci. 2004, 21, 251–260.

     OpenUrlPubMed
107. 107.↵
     1. Dowty M. E.,
     2. Knuth K. E.,
     3. Irons B. K.,
     4. Robinson J. R.

     Transport of thyrotropin releasing hormone in rabbit buccal mucosa in vitro. Pharm. Res. 1992, 9, 1113–1122.

     OpenUrlPubMed
108. 108.↵
     1. Hosny E. A.,
     2. Elkheshen S. A.,
     3. Saleh S. I.

     Buccoadhesive tablets for insulin delivery: in-vitro and in-vivo studies. Boll. Chim. Farm. 2002, 141, 210–217.

     OpenUrlPubMed
109. 109.↵
     1. Nakane S.,
     2. Kakumoto M.,
     3. Yukimatsu K.,
     4. Chien Y. W.

     Oramucosal delivery of LHRH: pharmacokinetic studies of controlled and enhanced transmucosal permeation. Pharm. Dev. Technol. 1996, 20 (3), 251–259.

     OpenUrl
110. 110.↵
     1. Taylan B.,
     2. Capan Y.,
     3. Guven O.,
     4. Kes S.,
     5. Hincal A. A.

     Design and evaluation of sustained release and buccal adhesive propronolol hydrochloride tablets. J. Controlled Release 1996, 38 (1), 11–20.

     OpenUrl
111. 111.↵
     1. Lesch C. A.,
     2. Squier C. A.,
     3. Cruchley A.,
     4. Williams D. M.,
     5. Speight P.

     The permeability of human oral mucosa and skin to water. J. Dent. Res. 1989, 68, 1345–1349.

     OpenUrlAbstract/FREE Full Text
112. 112.↵
     1. Beckett A. H.,
     2. Triggs E. J.

     Buccal absorption of basic drugs and its application as an in vivo model of passive drug transfer through lipid membranes. J. Pharm. Pharmacol. 1967, 19, 31S–41S.

     OpenUrlPubMed
113. 113.↵
     1. Benes L.,
     2. Claustrat B.,
     3. Horriere F.

     Transmucosal, oral controlled-release, transdermal drug administration in human subjects: A crossover study with melatonin. J. Pharm. Sci. 1997, 86, 1115–1119.

     OpenUrlCrossRefPubMedWeb of Science
114. 114.↵
     1. McQuinn R. L.,
     2. Kvam D. C.,
     3. Maser M. J.,
     4. Miller A. L.,
     5. Oliver A.

     Sustained oral mucosal delivery in human volunteers of buprenorphine from thin non-erodingmucoadhesive polymeric disks. J. Controlled Release 1995, 34, 243–250.

     OpenUrl
115. 115.↵
     1. Jain N. K.

     Controlled Release and Novel Drug Delivery, 1st ed.; CBS Publishers and Distributors: New Delhi, 1997; pp 353–370.
116. 116.↵
     1. Sonani N. G.,
     2. Hiremath S. P.,
     3. Dasankoppa F. S.,
     4. Jamakandi V. G.,
     5. Steenivas S. A.

     Design and evaluation of gastroretentive mucoadhesive cephalexin tablets. Pharm. Dev. Technol. 2010, 15 (2), 178–183.

     OpenUrlPubMed
117. 117.↵
     1. Gupta A.,
     2. Garg S.,
     3. Khar R. K.

     Measurement of bioadhesive strength of mucoadhesive buccal tablets: design of an in vitro assembly. Indian Drugs 1992, 30 (4), 152–155.

     OpenUrl
118. 118.↵
     1. Santos C. A.,
     2. Jacob J. S.,
     3. Hertzog B. A.,
     4. Carino G. P.,
     5. Mathiowitz E.

     Methods and Compositions for Enhancing the Bioadhesive Properties of Polymers Using Organic Excipients. U.S. Patent 6,156,348, December 5, 2000.
119. 119.↵
     1. Mathiowitz E.,
     2. Chickering D. E.,
     3. Lehr C. M.

     1. Hertzog B. A.,
     2. Mathiowitz E.

     Novel Magnetic Technique ToMeasure Bioadhesion. In Bioadhesive Drug Delivery Systems—Fundamentals Novel Approaches and Development; Mathiowitz E., Chickering D. E., Lehr C. M. Eds.; Marcel Dekker: New York, 1999; pp 147–171.
120. 120.↵
     1. Swarbrick J.,
     2. Boylan J. C.

     1. Kamath K. R.,
     2. Park K.

     Mucosal Adhesive Preparations. In Encyclopedia of Pharmaceutical Technology; Swarbrick J., Boylan J. C. Eds.; Marcel Dekker: New York, 1994; Vol. 10, pp 133–163.

     OpenUrlFREE Full Text
121. 121.↵
     1. Mikos A. G.,
     2. Peppas N. A.

     Bioadhesive analysis of controlled release systems. IV. An experimental method for testing the adhesion of microparticles with mucus. J. Controlled Release. 1990, 2 (2), 31–37.

     OpenUrl
122. 122.↵
     1. Riley R. G.,
     2. Smart J. D.,
     3. Tsibouklis J.,
     4. Dettmar P. W.,
     5. Hampson F.,
     6. Davis J. A.,
     7. Kelly G.,
     8. Wilber R. W.

     An investigation of mucus/polymer rheological synergism using synthesized and characterized poly (acrylic acid). Int. J. Pharm. 2001, 21 (7), 87–100.

     OpenUrl
123. 123.↵
     1. Park K.

     A new approach to study mucoadhesion: Colloidal gold staining. Int J. Pharm. 1989, 53, 209–217.

     OpenUrl
124. 124.↵
     1. Hassan E. E.,
     2. Gallo J. M.

     Simple rheological method for the in vitro assessment of mucin-polymer bioadhesive bond strength. Pharm. Res. 1990, 7, 491–498.

     OpenUrlPubMed
125. 125.↵
     1. Park K.,
     2. Robinson J. R.

     Bioadhesive polymers as platforms for oral controlled drug delivery: method to study bioadhesion. Int. J. Pharm. 1984, 19, 107–1279.

     OpenUrlCrossRefWeb of Science
126. 126.↵
     1. Mathiowitz E.

     1. Mathiowitz E.,
     2. Chickering D.,
     3. Jacob J. S.,
     4. Santos C.

     Bioadhesive Drug Delivery Systems. In Encyclopedia of Controlled Drug Delivery; Mathiowitz E. Ed.; Wiley: New York, 1999; Vol. 1, pp 9–44.

     OpenUrl
127. 127.↵
     1. Khurana R.,
     2. Ahuja A.,
     3. Khar R. K.

     Development and evaluation of mucoadhesive films of miconazole nitrate. Indian J. Pharm. Sci. 2000, 60, 449–453.

     OpenUrl
128. 128.↵
     1. Nafee N. A.,
     2. Boraie N. A.,
     3. Ismail F. A.,
     4. Mortada L. M.

     Design and characterization of mucoadhesive buccal patches containing cetylpyridinium chloride. Acta Pharm. 2003, 53, 199–212.

     OpenUrlPubMed
129. 129.↵
     1. Shivanand K.,
     2. Raju S. A.,
     3. Nizamuddin S.,
     4. Jayakar B.

     In vivo bioavailability studies of sumatriptan succinate buccal tablets. DARU J. Pharm. Sci. 2011, 19 (3), 224–230.

     OpenUrl
130. 130.↵
     1. Palem C. R.,
     2. Gannu R.,
     3. Yamsani S. K.,
     4. Yamsani V. V.,
     5. Yamsani M. R.

     Development of bioadhesive buccal tablets for felodipine and pioglitazone in combined dosage form: in vitro, ex vivo, and in vivocharacterization. Drug Del. 2011, 18 (5) 344–352.

     OpenUrl
131. 131.↵
     1. Bottenberg P.,
     2. Cleymaet R.,
     3. Muynek C. D.,
     4. Remon J. P.,
     5. Coomans D.,
     6. Slop D.

     Development and testing of bioadhesive, fluoride containing slow-release tablets for oral use. J. Pharm. Pharmacol. 1991, 43, 457–464.

     OpenUrlPubMed
132. 132.↵
     1. Nakamura F.,
     2. Ohta R.,
     3. Machida Y.,
     4. Nagai T.

     In vitro and in vivonasal mucoadhesion of water-soluble polymers. Int. J. Pharm. 1996, 134, 173–181.

     OpenUrl
133. 133.↵
     1. Shermer A.,
     2. Amicji B.,
     3. Trau H.,
     4. Nathansohn N.,
     5. Mizrahi B.,
     6. Domb A. J.

     Efficacy of a mucoadhesice patch compared with an oral solution for treatment of aphthous stomatitis. Drugs R. D. 2008, 9 (1), 29–35.

     OpenUrlPubMed
134. 134.↵
     1. Donnelly R. F.,
     2. McCarron P. A.,
     3. Tunney M. M.,
     4. Woolfson A. D.

     Potential of photodynamic therapy in treatment of fungal infections of the mouth. Design and characterization of a mucoadhesive patch containing toluidine blue. J. Photochem. Photobiol.B 2007, 86 (1), 59–69.

     OpenUrl
135. 135.↵
     1. Lee J.,
     2. Kellaway I. W.

     Buccal permeation of (D-Ala2, DLeu5) enkephalin from liquid crystalline phases of glyceryl monooleate. Int. J. Pharm. 2000, 195, 35–38.

     OpenUrlPubMed
136. 136.↵
     1. Modi G.,
     2. Mihic M.,
     3. Lewin A.

     Evolving role of oral insulin in the treatment of diabetes using a novel rapidmist system. Diabetes Metab. Res. Rev. 2002, 18 (Suppl. 1), S38–S42.

     OpenUrlCrossRefPubMed
137. 137.↵
     1. Yang T. Z.,
     2. Wang X. T.,
     3. Yan X. Y.,
     4. Zhang Q.

     Phospholipid deformable vesicles for buccal delivery of insulin. Chem. Pharm. Bull. 2002, 50 (6), 749–753.

     OpenUrlPubMed